to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses.
Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab.
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial.
Drug-Related Side Effects and Adverse Reactions
Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma.
Drug Related Side Effects and Adverse Reactions